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Abstract. The aim of the present study was to perform 
cytogenetic analysis by means of a semi-automated micro-
nucleus-centromere assay in lymphocytes from medical 
radiation workers. Two groups of workers receiving the 
highest occupational doses were selected: 10 nuclear medicine 
technicians and 10 interventional radiologists/cardiologists. 
Centromere-negative micronucleus (MNCM-) data, obtained 
from these two groups of medical radiation workers were 
compared with those obtained in matched controls. The blood 
samples of the matched controls were additionally used to 
construct a ‘low-dose’ (0-100 mGy) MNCM- dose-response 
curve to evaluate the sensitivity and suitability of the 
micronucleus-centromere assay as an ‘effect’ biomarker in 
medical surveillance programs. The physical dosimetry data 
of the 3 years preceding the blood sampling, based on single or 
double dosimetry practices, were collected for the interpreta-
tion of the micronucleus data. The in vitro radiation results 
showed that for small sized groups, semi-automated scoring 
of MNCM- enables the detection of a dose of 50 mGy. The 
comparison of MNCM- yields in medical radiation workers 
and control individuals showed enhanced MNCM- scores in 
the medical radiation workers group (P=0.15). The highest 
MNCM- scores were obtained in the interventional radiolo-
gists/cardiologists group, and these scores were significantly 
higher compared with those obtained from the matched 
control group (P=0.05). The higher MNCM- scores observed 
in interventional radiologists/cardiologists compared with 
nuclear medicine technicians were not in agreement with the 
personal dosimetry records in both groups, which may point 
to the limitation of ‘double dosimetry’ procedures used in 
interventional radiology/cardiology. In conclusion, the data 
obtained in the present study supports the importance of cyto-
genetic analysis, in addition to physical dosimetry, as a routine 
biomonitoring method in medical radiation workers receiving 
the highest occupational radiation burdens.
Introduction
Of all the workers exposed worldwide to man-made sources 
of ionizing radiation, medical radiation workers represent 
the largest group. Although the exposure levels in these 
subjects are generally low and in any case below the regula-
tory limit of 20 mSv per year, diagnostic procedures used 
in nuclear medicine and interventional cardiology/radiology 
can still represent a source of relatively high occupational 
exposure (1,2).
In nuclear medicine the highest exposures occur during the 
handling and administration to patients of fluorine‑18 fluoro-
deoxyglucose (18F‑FDG) for positron emission tomographic 
(PET) imaging. In the medical application of X-rays, the highest 
exposures are associated with interventional procedures in 
interventional radiology/cardiology, necessitating fluoros-
copy and cinefluorographic examinations. The occupational 
dose of staff working in interventional radiology/cardiology 
remains high despite the wearing of lead aprons. Workers 
receive doses from scattered radiation and the transmission of 
a small percentage of primary x-rays through the apron, and 
additionally, part of the body is unshielded. In interventional 
cardiology, the continuous developments in catheter device 
technology and procedures enable more challenging clinical 
indications to be handled. As a result, the number of inter-
ventional procedures, in addition to their complexity, increases 
together with the potential for interventional operators to 
receive higher doses of ionizing radiation (3). This raises 
some concern as epidemiological studies have indicated that 
medical radiation workers may show increased mortality due 
to leukemia and other neoplasias (4).
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Ionizing radiation is a potent mutagen and inducer of 
chromosomal aberrations, which are correlated with genetic 
alterations that may trigger the development of cancer. 
Chromosomal damage in peripheral blood lymphocytes 
induced by ionizing radiation can be assessed by cytogenetic 
techniques, such as the dicentric assay and the micronucleus 
assay. Cytogenetic studies performed on hospital workers 
occupationally exposed to low doses of ionizing radiation 
have indicated that even in cases where the levels of radiation 
received through occupational exposure were under regulatory 
limits, as registered by personal dosimetry, increased cytoge-
netic damage was observed, compared with the non-exposed 
subjects. By using chromosomal damage as ‘effect’ biomarker, 
cytogenetic biomonitoring provides important additional infor-
mation which complements physical dosimetry and enables 
better evaluation of the health effects of radiation (1,2,4-7).
Although cytogenetic analysis of dicentric formation is 
the gold standard for biological dosimetry, application of this 
technique for the biomonitoring of relatively large groups of 
radiation workers is not ideal, as dicentric analysis is complex, 
time consuming and requires highly skilled personnel. By 
contrast, the cytokinesis-block micronucleus (MN) assay is 
less laborious and presents a viable alternative for large-scale 
screening. The only disadvantage of this assay compared 
with the dicentric assay is the high frequency of background 
spontaneous micronuclei, making this technique less sensitive 
for the detection of low dose exposures (detection limit of 
0.2‑0.3 Gy) (8). However, combination of the MN assay with 
fluorescent in situ hybridisation (FISH) using a pan‑centromeric 
probe enables discrimination between radiation-induced 
centromere-negative MN (MNCM-), resulting mainly from 
acentric fragments, and spontaneous centromere-positive MN 
(MNCM+), which predominantly contain lagging chromo-
somes. Scoring of MNCM- has substantially increased the 
sensitivity of the technique for the biomonitoring of radiation 
workers (4). Although the FISH‑based MN‑centromere assay 
is more expensive and time consuming, new developments in 
FISH technology and the availability of computerized cytoge-
netic image analysis systems have overcome this problem. The 
semi-automated MN-centromere assay recently optimized by 
our research group combines high-speed MN analysis with 
a more accurate assessment of radiation damage in the low 
dose range (0.05-0.1 Gy), comparable to the dicentric assay. 
These characteristics of the semi-automated MN-centromere 
assay are of special interest for large-scale radiation exposure 
applications (9).
The aim of the present study was to perform a cytogenetic 
analysis by means of the semi-automated MN-centromere assay 
in the peripheral blood lymphocytes (PBL) of medical radia-
tion workers occupationally exposed to low doses of ionizing 
radiation (below the regulatory limits). Two groups of medical 
workers that receive the highest doses at their workplace were 
selected: Nuclear medicine technologists (NMTs) involved in 
PET applications and interventional cardiologists/radiologists. 
The MN data obtained from these workers were compared 
with a group of non-exposed, matched control individuals. 
The blood samples of the control individuals were additionally 
used to construct a ‘low dose’ (0-100 mGy) MN dose-response 
curve to evaluate the sensitivity of the MN assay in the low 
dose range and its suitability as bio-dosimeter in medical 
surveillance programs. For both groups of radiation workers, 
physical dosimetry data were collected for the interpretation 
of the MN data: Personal equivalent dose Hp(10) values for the 
nuclear medicine technicians and effective dose E values for 
the interventional X-ray workers. The results from the present 
study support the importance of cytogenetic analysis, in addi-
tion to physical dosimetry, as a routine biomonitoring method 
in medical radiation workers with the highest occupational 
radiation burdens.
Materials and methods
Study population. For the present study two groups of medical 
radiation workers were selected: 10 NMTs and 10 interven-
tional radiation workers (IRW). The NMT group was recruited 
from the following hospitals: University Hospital St-Luc, 
Iris Hospitals South, St-Anne St-Rémi Clinic (all Brussels, 
Belgium) and AZ St-Jan (Bruges, Belgium). The IRW group 
consisted of cardiologists and radiologists working in the 
following hospitals: Mont-Godinne Clinic (Yvoir, Belgium), 
Brugmann University Hospital (Brussels, Belgium), Hospital 
Oost-Limburg, Ghent University Hospital (Ghent, Belgium) 
and St-Luc (Brussels, Belgium). Two control groups, one for 
each category of exposed medical radiation workers (CONNMT 
and CONIRW), were comprised of age- and gender-matched 
individuals and included 19 subjects working in the same 
hospitals, however, with no history of exposure to ionizing 
radiation.
The study was approved by the ethics committee of St-Luc 
Clinical University (Brussels, Belgium). All participants were 
volunteers and each individual was provided with sufficient 
information to give an informed consent. None of the partici-
pants had undergone X-ray or isotope examinations during the 
previous 5 years, or had been exposed to other carcinogenic 
or mutagenic agents at work. None of the participants had 
experienced major medical problems or conditions during 
the previous 5 years. There was one smoker in the exposed 
group and one in the control group. The mean age of the NMT 
group, consisting of 4 males and 6 females, was 46.4 years 
(range: 26-64) compared with 45.7 years (range: 31-62) for 
the corresponding control group. The mean age of the IRW 
group (10 males) was 47.8 years (range: 41‑60) compared 
with 47.5 years (range: 42-56) for the controls. The age of the 
participants in the study ranged from 26-64 years. Heparinized 
blood samples from the radiation workers and matched 
controls were taken by venipuncture at the same time. Blood 
samples of the worker/control pairs were collected and coded 
in the Occupational Medicine Service, Centre de Services 
Interentreprises (CESI; University Hospital St-Luc, Iris 
Hospitals South, St-Anne St-Rémi Clinic and Mont-Godinne 
Clinic) and sent to the biodosimetry laboratory at Ghent 
University (Ghent, Brussels) for cytogenetic analysis.
Dosimetry records. The occupational radiation doses received 
in the years prior to the blood sampling performed in the present 
study had been routinely monitored by film badge personal 
dosimetry. In the case of nuclear medicine workers the dose 
estimates, Hp(10), are based on the monthly readings from 
personal dosimeters fixed at chest height to the hospital apron of 
the workers. Determination of the radiation doses of the IRWs 
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was performed by double dosimetry to compensate for the fact 
that part of the body is shielded by the lead apron and part of the 
body remains unshielded. One dosimeter was worn underneath 
the lead apron at chest or waist height, resulting in a dose under 
the apron, Hp,u(10), and the other is worn above the apron at 
chest height, resulting in a dose above the apron, Hp,o(10). The 
readings were combined to obtain the effective dose E using 
the algorithm E=0.79 Hp,u(10) + 0.100 Hp,o(10) (10). This algo-
rithm takes into account organs and weighting factors from the 
International Commission on Radiological Protection (11).
Personal dosimetry records for the 3 years preceding 
the blood sampling were collected for each radiation worker 
belonging to the study cohort. Dosimetry records older than 
3 years were not collected, as unstable chromosome aberra-
tions such as dicentrics and MN have an in vivo half-life of 
approximately 1 year. In addition, Thierens et al (12) reported 
that chromosomal damage induced greater than 3 years ago 
had almost completely disappeared.
Semi‑automated MN centromere assay
Cell culture and MN‑centromere assay. The day of blood 
sampling, two 5 ml whole blood cultures were set up per 
sample containing 0.3 ml blood in Roswell Park Memorial 
Institute 1640 medium with L-glutamine and 25 mM 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid buffer 
(HEPES) (Gibco; Thermo Fisher Scientific, Inc., Waltham, 
MA, USA) supplemented with 10% fetal calf serum (Gibco; 
Thermo Fisher Scientific, Inc.) and 100 µl phytohaemagglu-
tinin (PHA; stock solution 1 mg/ml) (Sigma-Aldrich, St Louis, 
MO, USA) used as a mitogen. At 23 h later, cytochalasin B 
(6 µg/ml, Sigma-Aldrich) was added to block cytokinesis. 
Cells were harvested 70 h following stimulation with PHA 
using a cold (4˚C) hypotonic shock with 0.075 M KCl (Merck 
Millipore, Darmstadt, Germany). This was followed by 
fixation in a solution containing methanol, acetic acid and 
ringer (0.9% NaCl) (4:1:5) and a further fixation in methanol, 
acetic acid (4:1; Merck Millipore) for three times (13). Cell 
suspensions were added dropwise onto clean slides. All slides 
were prepared in duplicate per culture and coded. For the 
analysis of centromere-negative MN, slides were dehydrated 
in alcohol series (70-90-100% ethanol) (Merck Millipore) 
and left to dry for 15 min prior to performing FISH with a 
home-tailored probe based on PCR technology. The details 
of the pan-centromeric probe production, dilution and label-
ling [Nick Translation method, Spectrum Orange (SpOr)] 
have been previously described in detail (9). For in situ 
hybridisation, 20 µl of the home‑tailored probe was placed 
onto a coverslip and applied to the slide. Probe and target 
DNAs were then denatured at 76˚C for 5 min and hybridised 
for 20 h at 38˚C using a ThermoBrite Temperature controlled 
slide processing system (Abbott Molecular, Des Plaines, IL, 
USA). Following hybridisation, the slides were placed in 2X 
saline sodium citrate (SSC) for 5 min to allow detachment of 
the coverslip. Post-hybridisation washing was performed in 
0.4X SSC/0.1% Tween at 72˚C (1 min) and in 2X SSC at room 
temperature (5 min). Finally, the slides were mounted with 
Vectashield containing 4',6-diamidino-2-phenylindole (DAPI) 
(Vector Laboratories, Inc., Burlingame, CA, USA).
Blood samples from 16 of the 19 control individuals were 
used to set up an in vitro ‘low‑dose’ dose‑response curve. For 
this, each blood sample was divided in four parts. One part 
was used as a sham-irradiated control while the others were 
exposed to 20, 50 and 100 mGy of 60Co γ-rays at a dose rate of 
0.1 Gy/min. For each dose point, two cultures were set up and 
processed as described above for MN-centromere analysis.
Semi‑automated MN‑centromere scoring. Microscopic anal-
ysis was conducted using a Metafer 4 platform (MetaSystems 
GmbH, Altlussheim, Germany) connected to a motorized Zeiss 
AxioImager M1 microscope (Zeiss, Oberkochen, Germany). 
Detailed information regarding the MSearch slide scanning 
procedure, stage movement, focusing and image acquisition 
are detailed in Willems et al (13) and Schunck et al (14).
First, automated MN scoring in binucleate (BN) cells on 
DAPI‑FISH stained slides was performed using a 10x objec-
tive, a DAPI filter and the Msearch and MNScore modules of 
MetaSystems (13). Secondly, all BN cells that were detected by 
MSearch were visually checked in the image gallery and BN 
cells with confirmed MN were marked for AutoCapt analysis. 
With the AutoCapt image acquisition software, the marked 
cells were relocated from the Metafer position list using a 
40x objective and image acquisition was performed with two 
colour channels (DAPI, SpOr). The two colour images were 
shown on the display and in the image gallery, and the MN 
were manually checked for the presence of centromeres. Fig. 1 
presents an example of a BN cell with a centromere-positive 
MN (MNCM+) containing a whole chromosome and a BN 
cell with a centromere-negative MN (MNCM-) consisting of 
an acentric fragment.
Semi‑automated analysis of MN in FISH‑DAPI stained 
slides, as described above, was performed to score the total 
number of MN (MN total), the number of MNCM- and 
MNCM+ in the non-irradiated and irradiated samples from 
the workers and healthy controls. Between 2,000 and 6,000 
BN cells were scored per condition.
Statistical analysis. All MN values are presented as the mean 
per 1,000 BN cells ± standard error of the mean. The personal 
dosimetry data is presented as the mean (mSv) ± standard 
deviation. Statistical analysis of the data was performed 
using SPSS software, version 23.0 (IBM SPSS, Armonk, MY, 
USA). Differences in the MN yields between in vitro doses 
were analysed by a Wilcoxon signed-rank test (intra-group 
analysis). For difference in MN yield between two or more 
groups the Wilcoxon rank‑sum test and the Kruskal‑Wallis test 
were used, respectively. Agreement between dose‑response fits 
and experimental data was quantified by the regression coef-
ficient R2. P≤0.05 was considered to indicate a statistically 
significant difference.
Results
In vitro MN dose response curves. Blood samples from the 16 
healthy control individuals (10 males, 6 females) were used to 
set up a dose-response curve in the low dose region. The mean 
dose-response data for MN total, MNCM- and MNCM+ are 
presented in Table I.
In Fig. 2, the linear‑quadratic dose‑response curves 
(Y = c + aD bD2 in which Y is the MN yield, c is the 
spontaneous MN count and D is the dose in mGy) 
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that were fitted through the mean MN total (MN 
total =13.0 + 1.15x10-2 D + 3.98x10 -4 D2; R2=0.988) and 
MNCM- values (MNCM‑ =2.68 + 2.53x10-2 D + 1.46x10-4 D2; 
R2=0.999) are presented. Table I and Fig. 2 present an increase 
in the total number of MN in the 0-100 mGy dose region, 
which may be attributed to an increase in MNCM-.
The yield of MNCM+ remains constant up to 50 mGy, 
with a slight increase at a dose of 100 mGy. Additionally, 
the percentages of MNCM- and MNCM+ are presented in 
Table I and show that spontaneous MN are predominantly 
centromere-positive (79%). With increasing doses, the 
percentage of MNCM+ reduced while the percentage of 
MNCM- increased, from 21% at 0 Gy to 37% at 100 mGy. A 
Wilcoxon signed-rank test was used to determine from which 
dose threshold significantly higher MN yields are obtained in 
our control group. For MNCM‑ a significant increase (P=0.032) 
was observed between 0 and 50 mGy, while for MN total a 
significant increase (P=0.003) was observed between 0 and 
100 mGy. When MNCM- were analysed, a significant increase 
was observed between 50 mGy and 100 mGy (P=0.004).
MN data in medical radiation workers compared with matched 
control individuals. A direct comparison of the mean values 
of MN total, MNCM- and MNCM+ between the two groups 
of radiation workers (n=19) and their matched control groups 
(n=19) is presented in Table II. In addition, the MNCM- data are 
presented graphically in Fig. 3. The IRWs exhibited increased 
but not significant (P=0.06) total MN yields, compared with 
their control group (CONIRW). With regards to MNCM-, the 
difference in MN yield between both groups was significant 
(P=0.05; Table II, Fig. 3). As the individuals in both groups are 
age‑ and gender‑matched, an influence of these variables in 
Table I. Total number of BN cells scored per dose for the 16 control individuals together with the mean MN scores and SEM for 
MN total (per 1,000 BN cells), MNCM- and MNCM+.
    MNCM-   MNCM+  
    (per 1,000  MNCM- (per 1,000  MNCM+
Dose (mGy) Total BN MN total SEM BN cells) SEM (%) BN cells) SEM (%)
    0 52252 12.84 1.53 2.65 0.29 21 10.19 1.45 79
  20 50301 13.74 1.22 3.30 0.31 24 10.44 1.19 76
  50 49964 14.36 1.29 4.27 0.50 30 10.09 1.17 70
100 46945 18.18 1.17 6.68 0.50 37 11.50 1.05 63
BN, binucleate; MN, micronuclei; SEM, standard error of the mean; MNCM-, centromere-negative MN yields; MNCM, centromere-positive 
MN yields.
 
Table III. Personal dosimetry data for the IRW and NMT groups presented as cumulative doses over periods of 12 and 36 months 
preceeding the blood sampling.
Group Dose estimates 12 months 36 months 36 months (corrected)
IRW (n=10) E (mSv) ± SD 1.92±1.37 6.03±4.71 2.61±1.81
NMT (n=9) Hp(10) (mSv) ± SD 4.95±2.00 17.02±7.01 7.07±2.39
The 36 months (corrected) values are the cumulative doses over 36 months, corrected for the disappearance of micronucleated cells with a 
half-life of 1 year. IRW, interventional radiation workers; NMT, nuclear medicine technologists; SD, standard deviation.
 
Table II. Mean MN yields for the groups of exposed workers compared with the matched control groups.
  All, n=19   IRW, n=10   NMT, n=9 
 ------------------------------------------------------------- ------------------------------------------------------------ --------------------------------------------------------------
MN yields Exposed CON P-value Exposed CON P-value Exposed CON P-value
MN totala 13.71 12.02 0.30 12.02 8.39 0.06 15.41 15.28 0.85
MNCM-a 3.34 (24) 2.51 (21) 0.15 3.99 (33) 2.44 (29) 0.05 2.70 (18) 2.58 (17) 0.68
MNCM+a 10.37 (76) 9.51 (79) 0.63 8.03 (67) 5.95 (71) 0.20 12.71 (82) 12.70 (83) 1.00
aValues are per 1,000 binucleate cells; the values in brackets the percentage of MNCM- or MNCM+ in MN total. P-values obtained from 
the Wilcoxon rank-sum test. MN, micronuclei; IRW, interventional radiation workers; NMT, nuclear medicine technologists; CON, controls; 
MNCM-, centromere-negative MN yields; MNCM+, centromere-positive MN yields.
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assessed MN scores may be ruled out. In the NMT group, no 
differences in MN yields (MN total, MNCM-, MNCM+) were 
observed in comparison with their matched control group 
(CONNMT) (Table II, Fig. 3).
Comparison of the four populations (the IRW and NMT 
groups with their corresponding control groups) using a 
Kruskal‑Wallis test indicated a significant difference in MN 
(P=0.02) and MNCM+ (P=0.01), however, not in MNCM- 
(P=0.17). Histogram analysis indicates that the significant 
differences are predominantly associated with low MN and 
MNCM+ values in the IRW control group.
Comparison of all radiation workers compared with all the 
controls reveals only a small increase in the yield of MN total 
in the radiation workers, with an increase in MNCM- scores 
being more pronounced, however, not significant (P=0.15).
Personal dosimetry analysis. The data obtained from the 
personal dosimetry records, the effective dose E for IRW and 
the personal dose equivalent Hp(10) for NMT, are presented 
in Table III. In this table these dose parameters are given as 
cumulative doses for periods of 12 and 36 months preceding 
the blood sampling. In addition, the E and Hp(10) values over 
36 months corrected for the disappearance of MN are addi-
tionally tabulated. To this end MN were assumed to disappear 
with an in vivo half-life of 1 year (12).
Table III indicates that according to the personal dosim-
etry data, the NMT group received a higher radiation burden 
compared with the IRW group.
Comparison between biological and physical dosimetry data. 
Fig. 4 presents an overview of the individual data points of 
both groups of radiation workers. Fig. 4 presents the MN yields 
(MN total and MNCM-) as a function of the cumulative dose 
over 36 months, corrected for the disappearance of MN with a 
half-life of 1 year (corrected, 36 months). Fig. 4 indicates that 
the IRWs exhibited higher chromosomal damage according to 
biological dosimetry analysis using the MN-centromere assay, 
however, received a lower radiation burden according to the 
personal dosimetry records.
Discussion
The first part of the present study aimed to improve a 
semi-automated MN centromere assay for the biological 
dosimetry of medical radiation workers exposed to low 
doses. Using a Wilcoxon signed-rank test, it was demon-
strated that for small group sizes of about 10-15 individuals, 
the semi-automated MNCM- scoring enables the discrimina-
tion between 0 Gy and 50 mGy, while with semi-automated 
scoring of MN total a significant difference was only 
observed between 0 Gy and 100 mGy. These results indi-
cate that MNCM- scoring markedly improved the detection 
capability of the assay. In earlier in vitro studies using the 
MN-centromere assay the lowest doses applied were 50 or 
100 mGy, and the detection limit reported ranged between 50 
and 100 mGy (9,15,16).
In the present study, spontaneous MN, present in 
non-irradiated samples, consisted mainly of MNCM+ (79%), 
Figure 1. Images of BN cells. (A) The BN cell contains a centromere‑positive MN. (B) The BN cell contains a centromere‑negative MN (no signal). Nuclei are 
counterstained with 4',6‑diamidino‑2‑phenylindole (magnification, x40). BN, binucleate; MN, micronuclei.
Figure 2. Dose‑response curves for the MN total yield and the MNCM‑ yield. 
Dose‑response curves are fitted using a weighted linear‑quadratic regression. 
Values are presented as the mean ± standard error on the mean of the 16 
control donors. MN, micronuclei; MNCM-, centromere-negative MN; BN. 
binucleate.
  A   B
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with the increase in MN following low-dose exposure attrib-
uted to an increase in the number of MNCM-. These data are 
in line with a previous study (9). Although the MN-centromere 
assay is more labour-intensive compared with the standard 
MN assay, the use of a home-tailored pan-centromeric probe 
and a semi-automated scoring procedure, described here 
and in Baeyens et al (9), keeps the expense and scoring time 
reasonably low. This makes the assay suitable for large-scale 
applications, such as for biomonitoring. An automated proce-
dure has additionally been developed for dicentric analysis, 
which is the gold standard for biological dosimetry. Though 
this procedure reduces the workload of the dicentric assay, it 
additionally reduces its sensitivity. Further investigation and 
validation is required before automated dicentric scoring can 
be applied for biomonitoring purposes (17).
In the second part of the current study, the semi-automated 
MN centromere assay was used to perform a direct comparison 
between exposed radiation workers (IRW and NMT) and two 
groups of matched controls (CONIRW and CONNMT).
A first analysis of the total MN yields indicated that there 
was no significant difference between the pooled exposed 
workers and the pooled controls. Notably, a significant differ-
ence was observed in MN and MNCM+ between the two 
exposed and control groups applying the Kruskal‑Wallis test, 
which may be attributed predominantly to the lower number of 
MN and MNCM+ in the CONIRW group. It should be noted that 
the IRW and CONIRW groups consist only of males while the 
NMT and CONNMT groups consist of 6 females and 4 males. 
When the controls are divided into two groups according to 
gender, higher numbers of MN total and MNCM+ per 1000 
BN cells are observed in females (females, MN total = 16.66, 
MNCM+ = 14.62; males, MN total = 10.28, MNCM+ = 7.38). 
Conversely MNCM- are comparable between these groups 
(2.04 vs. 2.90 MNCM‑). These data confirm other findings 
indicating that the centromere-positive subset of MN is more 
susceptible to gender effects and is higher in females compared 
with males. Age may additionally be a confounding factor, and 
previous studies have reported that the increase of MN with 
age is due to an increase in centromere-positive MN. In the 
present study, the confounding effect of age on the MN yields 
may be excluded, as the mean age in both the exposed and 
control groups were comparable, as all worker/control pairs 
were age-matched. The effects of age and gender on MNCM+ 
have been extensively described in Baeyens et al (9). In addi-
tion, it has been reported that the X-chromosome is often 
involved in spontaneous chromosome loss (18).
As the majority of spontaneous MN are MNCM+, scoring 
of only the MNCM- subset removes the ‘background noise’ 
represented by MNCM+, and considerably lowers the detection 
threshold of the MN assay for the in vivo biomonitoring of radia-
tion workers exposed to low radiation doses, according to their 
personal dosimetry records. Using telomeric and centromeric 
FISH staining, Lindberg et al (19) demonstrated that the majority 
of the centromere-negative MN harbour terminal acentric frag-
ments, supporting the observation that centromere-negative MN 
are a better indicator of radiation-induced damage.
In a number of studies where the standard MN assay was 
used to biomonitor radiation workers, heterogeneous and 
contradictory results have been reported (2). Ropolo et al (2) 
state that the MN content is not the sole factor responsible for 
the heterogeneity in the results. One important factor is that in 
the majority of MN studies, mixed populations of hospital staff 
are investigated. Only in few studies (including the present), 
is the MN analysis performed in specific groups of radia-
tion workers, such as those working in nuclear medicine and 
interventional cardiology, and who receive the highest levels 
of exposures. Another important factor responsible for the 
heterogeneous results of many studies is the way the personal 
dosimetry data are used as an exposure parameter. In certain 
studies, the estimated dose is based on personal dosimetry read-
ings during the previous 12 months, the previous 5-10 years 
or based on the accumulated dose during the entire time of 
employment. Only in few studies is a correction performed for 
Figure 4. The individual MN yields (MN total and MNCM‑) as a function 
of the cumulative effective dose E and personal equivalent dose Hp(10) 
over 36 months, corrected for disappearance of MN for the IRW and NMT 
groups, respectively. The lines indicate the linear regression analysis through 
the MNCM- data points for the IRW and NMT groups. MN, micronuclei; 
centromere-negative MN; IRW, interventional radiation workers; NMT, 
nuclear medicine technologists; BN, binucleate; corr, corrected.
Figure 3. Comparison of the mean number of centromere‑negative MN 
obtained from exposed radiation workers, IRW and NMT, and their matched 
controls. Values are presented as the mean ± standard error of the mean. IRW, 
interventional radiation workers; NMT, nuclear medicine technologists; MN, 
micronuclei; BN, binucleate.
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the disappearance of MN. In the current study, the personal 
doses registered during the previous 12 or 36 months, with 
or without a correction for MN disappearance were used as 
occupational exposure quantities.
Analysis of the centromere-negative MN in all exposed 
workers compared with control individuals indicated an 
increased number of MNCM- in the exposed group, however, 
this increase was not significant (P=0.15). When the exposed 
group was divided into two groups, based on the specific 
professional activities, a significantly increased MNCM- 
number was observed in the IRW group compared with their 
controls (P=0.05). A significant increase of MNCM‑ scores 
was not observed in the NMT group, indicating that the 
IRWs are exposed to higher levels of occupational radiation 
compared with the NMT group. The higher yield of MNCM- 
in the IRW group compared with the NMT group is however, 
not in agreement with the personal dosimetry records of both 
groups. Dose estimates for the IRW group are considerably 
lower than in the NMT group. In the IRW group, the effec-
tive dose E, deduced from double dosimetry readings, was 
used as the personal dose. For this calculation an algorithm 
was applied, which takes into account the organs and organ 
weighting factors of the ICRP 103 publication: E=0.79 Hp,u(10) 
+ 0.100 Hp,o(10) (10). A number of studies have already been 
published dealing with the α and β coefficients in the E=α 
Hp,u(10) + β Hp,o(10) expression. An overview of these coeffi-
cients indicates that the majority of algorithms adopt α values 
close to 1 and β values in the range 0.07-0.10 (20,21). Utilizing 
a different algorithm in the present study will not alter the E 
values for the IRW group to a large extent.
The discrepancies observed between the physical dose 
estimates and the biological effect in both groups of radiation 
workers may indicate the limitations of physical dosimetry, in 
particular in interventional radiology/cardiology. This has been 
reported in previous studies (1,2,7). Although in interventional 
radiology/cardiology, double dosimetry practice is recom-
mended and legally required in Belgium and other countries, 
its application in daily practice is not granted. For example, 
interventional radiologists/cardiologists do not always wear 
their (or both) dosimeters during interventions performed at 
different locations. Personal dosimeters are not always worn 
correctly at the right position; hence they are not representative 
of the exposure. In certain cases, dosimeters remain attached to 
the apron, meaning the dose is no longer personal. In the current 
study of interventional radiologists/cardiologists, no readings 
were obtained for the dosimeters worn under the apron in 102 
of 300 reading months, and for dosimeters worn above the 
apron in 46/270 reading months. Another consideration is that 
no consensus exists on the most suitable algorithm to calculate 
the effective dose from the two readings. The lower frequency 
of MNCM- observed in NMTs compared with IRWs may be 
associated with the personal dosimetry records in NMTs not 
wearing lead aprons and related to annihilation photons, which 
are more representative of the real radiation burden in these 
workers. Finally, it should be considered that the cytogenetic 
effects are associated with the blood dose and not the personal 
equivalent dose, Hp(10), and the effective dose, E, quantities 
which serve as tools to monitor radiation workers.
The present study demonstrates that a semi-automated 
MN-centromere assay is suitable for large-scale low dose 
biomonitoring. The observations of enhanced frequencies of 
centromere-negative MN, representing chromosomal damage, 
in medical radiation workers exposed to doses within the 
ICRP regulatory limits, according to their personal dosimetry 
records, further supports that chronic radiation exposure may 
be hazardous due to enhanced genotoxicity. These results 
indicate that any suggestions that the current dose limits are 
unnecessarily low and restrictive and could be raised, should 
be rejected.
The present study strengthens the importance of cytoge-
netic analysis performed together with physical dosimetry, as 
a routine biomonitoring method for medical workers receiving 
the highest occupational radiation burden. The disagreement 
between the differences in personal dosimetry data and cyto-
genetic results of the two groups of medical radiation workers 
may be associated with the fact that the application of double 
dosimetry in the daily practice of interventional X-ray workers 
is not evident, reducing the reliability of the resulting effective 
doses.
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